Oligomeric compounds and compositions for the use in modulation of microRNAs

Details for Australian Patent Application No. 2007211082 (hide)

Owner ISIS Pharmaceuticals, Inc.

Inventors Bhat, Balkrishen; Kinberger, Garth A.; Swayze, Eric E.; Esau, Christine

Agent Pizzeys

Pub. Number AU-B-2007211082

PCT Pub. Number WO2007/090073

Priority 60/805,204 19.06.06 US; 60/762,721 27.01.06 US

Filing date 27 January 2007

Wipo publication date 9 August 2007

Acceptance publication date 27 September 2012

International Classifications

C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 Mutation or genetic engineering - DNA or RNA fragments

C12N 15/113 Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

21 August 2008 PCT application entered the National Phase

  PCT publication WO2007/090073 Priority application(s): WO2007/090073

27 September 2012 Application Accepted

  Published as AU-B-2007211082

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007211085-Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor

2007211080-6-modified bicyclic nucleic acid analogs